Although the benefits of thrombolytic therapy are well established in patients younger than age 75 years with acute ST-elevation myocardial infarction, the value of thrombolytic treatment in ...

Recent clinical research also reveals another paradox in the theory that thrombolytic therapy works by opening obstructed IRAs. Lincoff and Topol [4] found that the high patency rates reported ...